The Role of BRAF Mutation and p53 Inactivation during Transformation of a Subpopulation of Primary Human Melanocytes
AUTOR(ES)
Yu, Hong
FONTE
American Society for Investigative Pathology
RESUMO
Melanocytic nevi frequently harbor oncogenic BRAF mutations, but only a minority progress to melanoma. In human melanocytes, persistent BRAFV600E expression triggers oncogene-induced senescence, which implies that bypass of oncogene-induced senescence is necessary for malignant transformation of melanocytes. We show that a subpopulation of primary human melanocytes with persistent expression of BRAFV600E do not enter oncogene-induced senescence, but instead survive despite heightened MAPK activity. Disruption of the p53 pathway using short-hairpin RNA initiated rapid growth of these V600E+ melanocytes in vitro. The resultant V600E+/p53sh melanocytes grew anchorage-independently in soft agar, formed pigmented lesions reminiscent of in situ melanoma in artificial skin reconstructs, and were weakly tumorigenic in vivo. Array comparative genomic hybridization analysis demonstrated that the transformed melanocytes acquired a substantial deletion in chromosome 13, which encodes the Rb1 tumor suppressor gene. Gene expression profiling study of nevi and melanomas showed that p53 target genes were differentially expressed in melanomas compared with nevi, suggesting a dysfunctional p53 pathway in melanoma in vivo. In summary, these data demonstrate that a subpopulation of melanocytes possesses the ability to survive BRAFV600E-induced senescence, and suggest that p53 inactivation may promote malignant transformation of these cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2684200Documentos Relacionados
- Loss of p53 protein during radiation transformation of primary human mammary epithelial cells.
- Frequent mutation of the p53 gene in human esophageal cancer.
- Isolation and characterization of a human p53 cDNA clone: expression of the human p53 gene.
- Mutation of p53 in primary biopsy material and cell lines from Hodgkin disease.
- p53 domains: structure, oligomerization, and transformation.
